Characterization of appican, the chondroitin sulfate proteoglycan form of the Alzheimer amyloid precursor protein

Neurodegeneration

Volumn 5, Issue 4, 1996, Pages 445-451

  Pangalos, Menelas N ^a,b   Shioi, Junichi ^a   Efthimiopoulos, Spiros ^a   Wu, Anfan ^a   Robakis, Nikolaos K ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Alzheimer's disease; APP; Inflammation; Proteoglycans

Indexed keywords

AMYLOID PRECURSOR PROTEIN; APPICAN; ISOPROTEIN; PROTEOCHONDROITIN SULFATE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ASTROCYTE; CELL ADHESION; CELL STRUCTURE; CELL TRANSFORMATION; CONFERENCE PAPER; EXON; GENE MUTATION; GENETIC TRANSFECTION; GLIOMA CELL; HUMAN; HUMAN CELL; NERVE CELL; NEUROBLASTOMA CELL; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE;

EID: 0030483787     PISSN: 10558330     EISSN: None     Source Type: Journal    
DOI: 10.1006/neur.1996.0061     Document Type: Conference Paper

References (58)

1. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD (1996) Scavenging of Alzheimer's amyloid β-protein by microglia in culture. J Neurosci Res 43:190-202
2. Aschner M, Lopachin JRM (1993) Astrocytes: Targets and mediators of chemical induced CNS injury. J Toxic Envir Health 38:329-342.
3. Behl C, Davis JB, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827
4. Bourdon M, Krusius T, Cambell S, Schwartz N, Ruoslahti E (1987) Identification and syntheses of a recognition signal for the attachment of GAGs to proteins. PNAS USA 84:3194-3198
5. Breen KC, Bruce M, Anderton BH (1991) β Amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J Neurosci Res 28:90-100
6. Brittis PA, Canning DR, Silver J (1992) Chondroitin sulfate as a regulator of neuronal patterning in the retina. Nature 255:733-736
7. Brunden KR, Richter Cook NJ, Chaturvedi N, Frederickson RC (1993) pH-dependent binding of synthetic beta-amyloid peptides to glycosaminoglycans. J Neurochem 61:2147-2154
8. Crystal H, Dickson D, Fuld P, Masur D, Scott R, Mehler M, Masdeu J, Kawas C, Aronson M, Wolfson L (1988) Clinico-pathologic studies in dementia: Non-demented subjects with pathologically confirmed Alzheimer's disease. Neurology 38:1682-1687
9. DeWitt DA, Silver J, Canning DR, Perry G (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer's disease. Exp Neurol 121:149-152
10. Ernst H, Zanin MKB, Everman D, Hoffman S (1995) Receptor mediated adhesive and anti-adhesive functions of chondroitin sulfate proteoglycan preparations from embryonic chicken brain. J Cell Science 108:3807-3816
11. Fraser PE, Nguyen JT, Chin DT, Kirschner DA (1992) Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloid fibril-proteoglycan interactions. J Neurochem 59:1531-1540
12. Fukumoto H, Asami-Odaka A, Suzuki N, Iwatsubo T (1996) Association of Aβ40-positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals. Neurodegeneration 5:13-17
13. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Liebowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature 373:523-527
14. Ghirinkar RS, Eng LF (1995) Chondroitin sulfate proteoglycan staining in astrocyte-Schwann cell co-cultures. Glia 14:145-152
15. Giaccone G, Tagliavini F, Linoli G, Bouras C, Frigerior L, Frangione B, Bugiani O (1989) Down's patients: Extracellular preamyloid deposits precede neuritic degeneration and senile plaques. Neurosci Lett 97:232-238
16. Glenner G, Wong C (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120:885-890
17. Gupta-Bansal R, Ziehler W, Wujek JR, Brunden KR (1993) Potential role of proteoglycans in the accumulation and presistence of Aβ in Alzheimer's disease senile plaques. Soc Neurosci Abstr 19:1471
18. Kang J, Lemaire H, Unterbeck A, Salbaum J, Masters CL, Grzeschik K, Multhaup G, Beyreuther K, Muller-Hill B (1987) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature 325:733-736
19. Karlsson KL, Lindahl U, Marklund SL (1988) Binding of human extracellular superoxide dismutase C to sulfated glycosaminoglycans. Biochem J 256:29-33
20. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H (1988) Novel precursor of Alzheimer's disease amyloid precursor protein shows protease inhibitory activity. Nature 331:530-532
21. Konig G, Monning U, Czech C, Prior R, Banati R, Schreiter-Gasser U, Bauer J, Masters CL, Beyreuther K (1992) Identification of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leucocytes and microglial cells. J Biol Chem 267:10804-10809
22. Lorenzo A, Yankner BA (1994) β Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc Natl Acad Sci USA 91:12243-12247
23. Mann DMA, Iwatsubo T, Ihara Y, Cairns NJ, Lantos PL, Bogdanovic N, Lannfelt L, Winblad B, Maat-Schieman LC, Rossor MN (1996) Predominant deposition of amyloid-β 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyoid precursor protein gene. Am J Pathol 148:1257-1266
24. Margolis RK, Margolis RU (1993) Nervous tissue proteoglycans. Experientia 49:429-446
25. Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer's disease and Down Syndrome. Proc Natl Acad Sci USA 82:4245-4249
26. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-Amyloid peptides destabilize calcium homeostasis and render human neurons vulnerable to excitotoxicity. J Neurosci 12:376-389
27. Maxwell WL, Follows R, Ashurst DE, Berry M (1990) The response of the cerebral hemisphere of the rat to injury. 1. The mature rat. Philos Trans R Soc Lond 328:479-513
28. Okamato M, Mori S, Ichimura M, Endo H (1994) Chondroitin sulfate proteoglycans protect cultured rat's cortical and hippocampal neurons from delayed cell death induced by excitatory amino acids. Neurosci Lett 172:51-54
29. Pangalos MN, Efthimiopoulos S, Shioi J, Robakis J (1995a) The chondroitin sulfate attachment site of appican is formed by splicing out exon 15 of the amyloid precursor gene. J Biol Chem 270:10388-10391
30. Pangalos MN, Shioi J, Robakis NK (1995b) Expression of the chondroitin sulfate proteoglycans of amyloid precursor (appican) and amyloid precursor-like protein 2. J Neurochem 65:762-769
31. Pike CJ, Cummings BJ, Cotman CW (1995) Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp Neurol 132:172-179
32. Pollack SJ, Sadler IIJ, Hawtin SR, Tailor VJ, Shearman MS (1995) Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of β amyloid in rat PC12 cells. Neurosci Lett 184:113-116
33. Rakic P (1972) Mode of cell migration to the superficial layers of fetal monkey neocortex. J Comp Neurol 145:61-84
34. Regland B, Gottfries C (1992) The role of amyloid β-protein in Alzheimer's disease. Lancet 340:467-469
35. Robakis NK, Ramakrishna N, Wolfe G, Wisniewski HM (1987) Molecular cloning and characterisation of a cDNA encoding the cerebral vascular and the neuritic plaque core amyloid peptides. PNAS USA 84:4190-4194
36. Robakis NK, Pangalos MN (1994) Involvement of amyloid as a central step in the development of Alzheimer's disease. Neurobiol Aging 15:S127-S129
37. Ruoslahti E, Yamaguchi Y (1991) Proteoglycans as modulators of growth factor activities. Cell 64:867-869
38. Schubert D, LaCorbiere M, Saitoh T, Cole G (1989) The regulation of amyloid β protein precursor and its modulatory role in cell adhesion. Neuron 3:689-694
39. Selkoe DJ (1989) Molecular pathology of amyloidogenic proteins and the role of vascular amyloidosis in Alzheimer's disease. Neurobiol Aging 10:387-395
40. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325-327
41. Shaffer LM, Dority MD, Gupta-Bansal R, Frederickson RCA, Younkin SG, Brunden KR (1995) Amyloid β protein (Aβ) removal by neuroglial cells in culture. Neurobiol Aging 16:737-745
42. Shioi J, Anderson JP, Ripellino JA, Robakis NK (1992) Chondroitin sulfate proteoglycan form of the Alzheimer's beta-amyloid precursor. J Biol Chem 267:13819-13822
43. Shioi J, Refolo LM, Efthimiopoulos S, Robakis NK (1993) Chondroitin sulfate proteoglycan form of cellular and cell-surface Alzheimer amyloid precursor. Neurosci Lett 154:121-124
44. Shioi J, Pangalos MN, Ripellino JA, Vassilacopoulou D, Mytilineou C, Margolis RU, Robakis NK (1995) The Alzheimer amyloid precursor proteoglycan (Appican) is present in brain and is produced by astrocytes but not neurons in primary cultures. J Biol Chem 270:11839-11844
45. Snow AD, Kisilevsky R (1985) Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study. Lab Invest 53:37-44
46. Snow AD, Sekiguchi R, Nochlin D, Fraser P, Kimata K, Mizutani A, Arai M, Schreier WA, Morgan DG (1994a) An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloid in rat brain. Neuron 12:219-234
47. Snow AD, Sekiguchi RT, Nochlin D, Kalaria RN, Kimata K (1994b) Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not of cerebellum in Alzheimer's disease brain. Am J Pathol 144:337-347
48. Snow AD, Nochlin D, Skiguchi R, Carlson SS (1996) Identification and immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease. Exp Neurol 138:305-317
49. Snow DM, Lemmon V, Carrino D, Caplan A, Silver J (1990) Sulfated proteoglycans in astroglial barriers inhibit neurite outgrowth in vitro. Exp Neurol 109:111-130
50. Southwick PC, Yamagata SK, Echols CL, Higson GJ, Neynaber SA, Parson RE, Munroe WA (1996) Assessment of amyloid β protein in CSF as an aid in the diagnosis of Alzheimer's disease. J Neurochem 66:259-265
51. Su JH, Cummings BJ, Cotman CW (1992) Localization of heparan sulfate glycosaminoglycan and proteoglycan core protein in aged brain and Alzheimer's disease. Neuroscience 51:801-813
52. Thinakaran G, Sisodia SS (1994) Amyloid precursor-like protein 2 (APLP2) is modified by the addition of chondroitin sulfate glycosaminoglycan at a single site. J Biol Chem 269:22099-22104
53. Wasco W, Tanzi RE (1995) Molecular genetics of amyloid and apolipoprotein E in Alzheimer's disease. In Dawbarn D, Allen SJ (eds), Neurobiology of Alzheimer's Disease, Bios Scientific, Oxford, pp. 51-76
54. Woods AG, Cribbs DH, Whittemore ER, Cotman CW (1995) Heparan sulfate and chondroitin sulfate glycosaminoglycans attenuate β amyloid (25-35) induced neurodegeneration in cultured hippocampal neurons. Brain Res 697:53-62
55. Wujek JR, Dority MD, Frederickson RCA, Brunden KR (1996) Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro. Neurobiol Aging 17:107-113
56. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 250:279-281
57. Zebrower M, Beeber C, Kieras FJ (1993) Proteoglycan synthesis in Alzheimer's disease fibroblasts. Soc Neurosci Abstr 19:164
58. Zhan S, Veerhuis R, Kamphorst W, Eikelenboom P (1995) Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. Neurodegeneration 4:291-297